Last week, German lender DZ Bank AG filed a lawsuit against Morgan Stanley (MS), for misrepresentation of documents while selling mortgage-backed securities (MBS). The complaint indicts Morgan Stanley of presenting modified documents related to the sale of more than $694 million in residential mortgage-backed securities (RMBS).
The German lender accused Morgan Stanley of issuing misleading statements with omissions related to mortgage-backed securities and concealment of risks associated with these securities. The plaintiff claims that the documents used for offering the securities contained fraudulent statements or omissions regarding the risks associated with the investments. Misinterpretation of these risks led to the investments, which incurred losses at current levels.
The case has been filed in the New York State Supreme Court in Manhattan and the company demands compensation for the damages. However, Morgan Stanley has refrained from commenting on the issue.
Others Facing Similar Issues
This year, similar actions has been taken against other banking majors, including JPMorgan Chase & Co. (JPM), HSBC Holdings Plc. (HBC), UBS AG (UBS), Citigroup Inc. C), Bank of America Corporation (BAC) and The Goldman Sachs Group Inc. (GS).
Trouble has been brewing for Morgan Stanley for quite sometime now, as only recently it was sued by two other German lenders - IKB Deutsche Industriebank AG (IKB) and HSH Nordbank AG in the Supreme Court over the same issue worth $147.1 million and $524 million, respectively.
A slew of lawsuits have continued for major U.S. banks since the financial meltdown. Numerous lawsuits alleging banks of such wrongdoings are expected to tarnish their reputation and financials over time. However, investors and other financial institutions bearing the brunt of these faulty practices are expected to be fairly compensated.
Morgan Stanley currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We believe such lawsuits against the company might lead to negative estimate revisions, which in turn may result in a downgrade in the Zacks Rank.